Bolt Biotherapeutics
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
900 Chesapeake Dr, Redwood City, Califor...Phone Number
(650) 665-9295Website
www.boltbio.comRevenue
$6.5 MillionStock Symbol
BOLTIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Bolt Biotherapeutics
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City,Read more
Bolt Biotherapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bolt Biotherapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Bolt Biotherapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Bolt Biotherapeutics recently announced quarterly report
Product Launch: Get notified when Bolt Biotherapeutics launches new products
Check out if Bolt Biotherapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Bolt Biotherapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Bolt Biotherapeutics
Click to see if Bolt Biotherapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Bolt Biotherapeutics has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Bolt Biotherapeutics
Compare insights from companies similar to Bolt Biotherapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Bolt Biotherapeutics
$6.5M
11-50
Public
$340.5M
2015
SV
Samara VioletSenior Director, Project Management
Company Profile Activity
Activity Insights
Bolt Biotherapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Bolt Biotherapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Bolt Biotherapeutics.
Bolt Biotherapeutics financials insights
Gather financial insights about Bolt Biotherapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series A
$17M
2020
Series C
$93.5M
2021
Stock Offering
$230M
Bolt Biotherapeutics Tech Stack
A closer look at the technologies used by Bolt Biotherapeutics
Most Recent Scoops
Earnings
Earnings, Finance
Earnings
Earnings, Finance
Earnings
Earnings, Finance
Earnings
Earnings, Finance
Earnings
Earnings, Finance
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bolt Biotherapeutics
Sign Up For FreeTo access detailed company insights
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, color... Read More
